TAYSHA GENE THERAPIES INC
TSHA·877619106·US·Common Stock·Healthcare - Biotechnology-13D/G
TSHA (TAYSHA GENE THERAPIES INC) is held by 126 institutional investors as of Q2 2026. Largest holders: Avoro Capital Advisors LLC ($162.7M), RA CAPITAL MANAGEMENT, L.P. ($160.4M), GOLDMAN SACHS GROUP INC ($154.7M). Net institutional sentiment: Bullish.
126
Holders
(10 Elite)
$1.6B
Total Value
70% (125)
Consensus
88 buying - 37 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 14, 2026 · Insiders Jul 10, 2026 · Activists Aug 14, 2026 · Congress none
InsiderNSNagendran SukumarSell $1.2MJul 10, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 133
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer